✦ LIBER ✦

Variants of Uncertain Significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling

✍ Scribed by Moghadasi, S.; Hofland, N.; Wouts, J. N.; Hogervorst, F. B. L.; Wijnen, J. T.; Vreeswijk, M. P. G.; van Asperen, C. J.

Book ID: 126459458
Publisher: BMJ Publishing Group
Year: 2012
Tongue: English
Weight: 263 KB
Volume: 50
Category: Article
ISSN: 0022-2593
DOI: 10.1136/jmedgenet-2012-100961

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and in silico analysis of BRCA

Molecular and in silico analysis of BRCA1 and BRCA2 variants

✍ Stefania Tommasi; Brunella Pilato; Rosamaria Pinto; Alessandro Monaco; Michele B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Functional Assays for Analysis of Varian

Functional Assays for Analysis of Variants of Uncertain Significance in BRCA2

✍ Guidugli, Lucia; Carreira, Aura; Caputo, Sandrine M.; Ehlen, Asa; Galli, Alvaro; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

BRCA1 and BRCA2 sequence variants in hea

BRCA1 and BRCA2 sequence variants in healthy women in Croatia analyzed by high-resolution melting and in silico analysis of variants of unknown clinical significance

✍ S. Levanat; M. Levacic Cvok; M. Cretnik; V. Musani; P. Ozretic 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

A review of a multifactorial probability

A review of a multifactorial probability based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

✍ Noralane M. Lindor; Lucia Guidugli; Xianshu Wang; Maxime P. Vallée; Alvaro N. A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

A review of a multifactorial probability

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

✍ Noralane M. Lindor; Lucia Guidugli; Xianshu Wang; Maxime P. Vallée; Alvaro N. A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

Clinical mutation screening of the BRCA1 and BRCA2 genes for the presence of germline inactivating mutations is used to identify individuals at elevated risk of breast and ovarian cancer. Variants identified during screening are usually classified as pathogenic (increased risk of cancer) or not path

A Systematic Genetic Assessment of 1,433

A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes

✍ Douglas F. Easton; Amie M. Deffenbaugh; Dmitry Pruss; Cynthia Frye; Richard J. W 📂 Article 📅 2007 🏛 American Society of Human Genetics 🌐 English ⚖ 729 KB